• রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
Indications:
MIRABEG ER 25 MG is indicated for treatment of overactive bladder symptoms such as urgency, frequency, and urge urinary incontinence.
Pharmacology:
Mirabegron is a selective beta-3 adrenergic receptor agonist that relaxes the detrusor muscle during the bladder filling phase, increasing bladder capacity and reducing symptoms.
Dosage:
The usual starting dose is 25 mg once daily, orally, with possible increase to 50 mg based on clinical response and tolerance.
Administration:
Take the extended-release tablet orally with or without food at the same time each day.
Interaction:
May interact with drugs metabolized by CYP2D6, digoxin, and antihypertensive agents. Inform your healthcare provider of all medications.
Contraindications:
Severe uncontrolled hypertension, hypersensitivity to mirabegron, severe renal or hepatic impairment.
Side Effects:
Common side effects include hypertension, headache, urinary tract infection, nasopharyngitis, and dizziness.
Pregnancy & Lactation:
Use only if clearly needed and prescribed by a doctor. Consult your healthcare provider before use during pregnancy or breastfeeding.
Therapeutic Class:
Beta-3 adrenergic receptor agonist, urinary bladder relaxant.
Storage Conditions:
Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of reach of children.